QQQ   386.76 (-0.14%)
AAPL   193.02 (-0.21%)
MSFT   369.81 (-0.73%)
META   320.44 (+0.68%)
GOOGL   130.75 (-0.18%)
AMZN   145.62 (-0.86%)
TSLA   244.83 (+2.56%)
NVDA   464.32 (-0.29%)
NIO   8.10 (+9.02%)
BABA   72.17 (-0.29%)
AMD   119.33 (+0.80%)
T   16.96 (-1.51%)
F   10.79 (+1.79%)
MU   73.89 (+0.27%)
CGC   0.68 (+2.73%)
GE   120.47 (+0.20%)
DIS   92.15 (+1.50%)
AMC   6.95 (-1.00%)
PFE   29.21 (+0.41%)
PYPL   60.10 (+3.76%)
XOM   99.23 (-1.20%)
QQQ   386.76 (-0.14%)
AAPL   193.02 (-0.21%)
MSFT   369.81 (-0.73%)
META   320.44 (+0.68%)
GOOGL   130.75 (-0.18%)
AMZN   145.62 (-0.86%)
TSLA   244.83 (+2.56%)
NVDA   464.32 (-0.29%)
NIO   8.10 (+9.02%)
BABA   72.17 (-0.29%)
AMD   119.33 (+0.80%)
T   16.96 (-1.51%)
F   10.79 (+1.79%)
MU   73.89 (+0.27%)
CGC   0.68 (+2.73%)
GE   120.47 (+0.20%)
DIS   92.15 (+1.50%)
AMC   6.95 (-1.00%)
PFE   29.21 (+0.41%)
PYPL   60.10 (+3.76%)
XOM   99.23 (-1.20%)
QQQ   386.76 (-0.14%)
AAPL   193.02 (-0.21%)
MSFT   369.81 (-0.73%)
META   320.44 (+0.68%)
GOOGL   130.75 (-0.18%)
AMZN   145.62 (-0.86%)
TSLA   244.83 (+2.56%)
NVDA   464.32 (-0.29%)
NIO   8.10 (+9.02%)
BABA   72.17 (-0.29%)
AMD   119.33 (+0.80%)
T   16.96 (-1.51%)
F   10.79 (+1.79%)
MU   73.89 (+0.27%)
CGC   0.68 (+2.73%)
GE   120.47 (+0.20%)
DIS   92.15 (+1.50%)
AMC   6.95 (-1.00%)
PFE   29.21 (+0.41%)
PYPL   60.10 (+3.76%)
XOM   99.23 (-1.20%)
QQQ   386.76 (-0.14%)
AAPL   193.02 (-0.21%)
MSFT   369.81 (-0.73%)
META   320.44 (+0.68%)
GOOGL   130.75 (-0.18%)
AMZN   145.62 (-0.86%)
TSLA   244.83 (+2.56%)
NVDA   464.32 (-0.29%)
NIO   8.10 (+9.02%)
BABA   72.17 (-0.29%)
AMD   119.33 (+0.80%)
T   16.96 (-1.51%)
F   10.79 (+1.79%)
MU   73.89 (+0.27%)
CGC   0.68 (+2.73%)
GE   120.47 (+0.20%)
DIS   92.15 (+1.50%)
AMC   6.95 (-1.00%)
PFE   29.21 (+0.41%)
PYPL   60.10 (+3.76%)
XOM   99.23 (-1.20%)

Prothena (PRTA) Earnings Date, Estimates & Call Transcripts

$36.65
+1.27 (+3.59%)
(As of 11:59 AM ET)
Compare
Today's Range
$35.11
▼
$36.86
50-Day Range
$32.31
▼
$52.32
52-Week Range
$28.51
▼
$79.65
Volume
93,856 shs
Average Volume
508,312 shs
Market Capitalization
$1.97 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$91.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Feb. 22Estimated
Actual EPS
(Nov. 2)
$0.38 Beat By $0.64
Consensus EPS
(Nov. 2)
-$0.26
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

PRTA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PRTA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Prothena Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20231($0.88)($0.88)($0.88) 
Q2 20231($0.88)($0.88)($0.88) 
Q3 20232($1.28)($0.92)($1.10) 
Q4 20232($1.30)($1.03)($1.17) 
FY 20236($4.34)($3.71)($4.03) 
Q1 20242($1.17)($1.16)($1.17) 
Q2 20242($1.23)($1.22)($1.23) 
Q3 20242($1.26)($0.95)($1.11) 
Q4 20242($1.37)($1.28)($1.33) 
FY 20248($5.03)($4.61)($4.82) 
Q1 20251($1.22)($1.22)($1.22) 
Q2 20251($1.30)($1.30)($1.30) 
Q3 20251($0.52)($0.52)($0.52) 

PRTA Earnings Date and Information

Prothena last announced its quarterly earnings data on November 2nd, 2023. The biotechnology company reported $0.38 EPS for the quarter, topping the consensus estimate of ($0.26) by $0.64. The business had revenue of $84.87 million for the quarter, compared to analyst estimates of $51.85 million. Prothena has generated ($1.42) earnings per share over the last year (($1.42) diluted earnings per share). Earnings for Prothena are expected to decrease in the coming year, from ($2.76) to ($4.82) per share. Prothena has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 22nd, 2024 based off prior year's report dates.

Prothena Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/22/2024
Estimated)		------- 
11/2/2023Q3 2023($0.26)$0.38+$0.64$0.38$51.85 million$84.87 million
8/3/2023Q2 2023($0.92)($1.03)($0.11)($1.03)$5.09 million$4.02 million  
5/4/2023Q1 2023($0.83)($0.89)($0.06)($0.89)$7.53 million$2.17 million  
2/23/2023Q4 2022($0.64)$0.12+$0.76$0.12$29.14 million$49.90 million    
11/3/2022Q3 2022($0.31)($0.97)($0.66)($0.97)$26.74 million$1.52 million
8/8/2022Q2 2022($0.51)($0.88)($0.37)($0.88)$20.12 million$1.31 million
5/5/2022Q1 2022($0.85)($0.78)+$0.07($0.78)$0.23 million$1.15 million
2/17/2022Q4 2021($0.74)($0.71)+$0.03($0.71)$0.28 million$1.17 million    
11/4/2021Q3 2021$2.25$2.13($0.12)$2.13$140.08 million$139.17 million
8/5/2021Q2 2021$0.56$0.58+$0.02$0.58$60.14 million$60.07 million
5/10/2021Q1($0.80)($0.91)($0.11)($0.91)$0.17 million$0.16 million    
2/10/2021Q4 2020($0.77)($0.77)-($0.77)$0.20 million$0.36 million  












Prothena Earnings - Frequently Asked Questions

When is Prothena's earnings date?

Prothena has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 22nd, 2024 based off last year's report dates. Learn more on PRTA's earnings history.

Did Prothena beat their earnings estimates last quarter?

In the previous quarter, Prothena (NASDAQ:PRTA) reported $0.38 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.26) by $0.64. Learn more on analysts' earnings estimate vs. PRTA's actual earnings.

How much revenue does Prothena generate each year?

Prothena (NASDAQ:PRTA) has a recorded annual revenue of $53.90 million.

How much profit does Prothena generate each year?

Prothena (NASDAQ:PRTA) has a recorded net income of -$116.95 million. PRTA has generated -$1.42 earnings per share over the last four quarters.

What is Prothena's EPS forecast for next year?

Prothena's earnings are expected to decrease from ($2.76) per share to ($4.82) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:PRTA) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -